Olfactory Function and Diffusion Tensor Imaging as Markers of Mild Cognitive Impairment in Early Stages of Parkinson's Disease

1. Lew, MF, Yeung, Y. Parkinson's disease. Reference module in biomedical science. Elsevier; 2014.
Google Scholar2. Wojtala, J, Heber, IA, Neuser, P, et al. Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition. J. Neurol, Neurosurg. Psychiatry. 2019;90(2):171-179.
Google Scholar | Crossref | Medline3. Braak, H, Ghebremedhin, E, Rüb, U, Bratzke, H, Del Tredici, K. Stages in the development of Parkinson's disease-related pathology. Cell and Tissue Research. 2004;318(1):121-134.
Google Scholar | Crossref | Medline | ISI4. Aarsland, D, Andersen, K, Larsen, JP, Lolk, A. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch. Neurol. 2003;60(3):387-392.
Google Scholar | Crossref | Medline5. Pedersen, KF, Larsen, JP, Tysnes, OB, Alves, G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurol. 2017;88(8):767-774. doi: 10.1212/WNL.0000000000003634
Google Scholar | Crossref | Medline6. Litvan, I, Goldman, J, Tröster, A, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Mov. Disord. 2012;27(3):349-356.
Google Scholar | Crossref | Medline | ISI7. Domellöf, ME, Ekman, U, Forsgren, L, Elgh, E. Cognitive function in the early phase of Parkinson's disease, a five-year follow-up. Acta Neurol. Scand. 2015;132(2):79-88. doi: 10.1111/ane.12375
Google Scholar | Crossref | Medline | ISI8. Wood, K-L, Myall, DJ, Livingston, L, et al. Different PD-MCI criteria and risk of dementia in Parkinson's disease: 4-year longitudinal study. NPJ Parkinsons Dis. 2016;2(1):15027. doi: 10.1038/npjparkd.2015.27
Google Scholar | Crossref | Medline9. Hobson, P, Meara, J. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort. Int. J. Geriatr. Psychiatry. 2015;30(10):1048-1055.
Google Scholar | Crossref | Medline10. Jones, JD, Kuhn, TP, Szymkowicz, SM. Reverters from PD-MCI to cognitively intact are at risk for future cognitive impairment: analysis of the PPMI cohort. Parkinsonism & Related Disorders. 2018;47:3-7. https://doi.org/10.1016/j.parkreldis.2017.12.006
Google Scholar | Crossref | Medline11. Doty, R, Hawkes, C, Good, KP, Duda, J. Odor perception and neuropathology in neurodegenerative diseases & schizophrenia. In: The Handbook of Olfaction and Gustation. 3rd (Vol. 3, pp. 403-452) ed. Wiley 2015; 2015.
Google Scholar | Crossref12. Meusel, T, Westermann, B, Fuhr, P, Hummel, T, Welge-Lüssen, A. The course of olfactory deficits in patients with Parkinson's disease—A study based on psychophysical and electrophysiological measures. Neurosci. Lett. 2010;486(3):166-170.
Google Scholar | Crossref | Medline13. Doty, RL, Deems, DA, Stellar, S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurol. 1988;38(8):1237-1244.
Google Scholar | Crossref | Medline14. Braak, H, Bohl, JR, Muller, CM, Rub, U, de Vos, RA, Del Tredici, K. Stanley fahn lecture 2005: the staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered. Mov Disord. 2006;21(12):2042-2051.
Google Scholar | Crossref | Medline | ISI15. Fullard, ME, Tran, B, Xie, SX, et al. Olfactory impairment predicts cognitive decline in early Parkinson's disease. Parkinsonism Relat. Disord. 2016;25:45-51.
Google Scholar | Crossref | Medline16. Rolheiser, TM, Fulton, HG, Good, KP, et al. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease. Journal of Neurology. 2011;258(7):1254-1260.
Google Scholar | Crossref | Medline17. Joshi, N, Rolheiser, T, Fisk, M, et al. Lateralized microstructural changes in early-stage Parkinson's disease in anterior olfactory structures, but not in substantia nigra. J. Neurol. 2017;264(7):1497-1505.
Google Scholar | Crossref | Medline18. Hoehn, M, Yahr, M. Parkinsonism: onset, progression and mortality. Neurol. 1967;17(5):427-442.
Google Scholar | Crossref | Medline | ISI19. Wechsler, D . Wechsler abreviated scale of intelligence (WASI) manual. Psychological Corporation; 1999.
Google Scholar20. Woods, SP, Delis, DC, Scott, JC, Kramer, JH, Holdnack, JA. The California verbal learning test--second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol. 2006;21 (5):413-420.
Google Scholar | Crossref21. Smith, A . Symbol Digits Modalities Test: Manual. Western Psychological Services; 2007.
Google Scholar22. Delis, DC, Kaplan, E, Kramer, J. Delis Kaplan executive function system. The Psychological Corporation; 2001.
Google Scholar23. Wechsler, D . Wechsler memory scale. 3rd ed. The Psychological Corporation; 1997.
Google Scholar24. Hoops, S, Nazem, S, Siderowf, AD, et al. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurol. 2009;73(21):1738-1745.
Google Scholar | Crossref | Medline | ISI25. Janvin, CC, Larsen, JP, Aarsland, D, Hugdahl, K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Movement Disorders: Official Journal of the Mov. Disord. 2006;21(9):1343-1349.
Google Scholar | Crossref | Medline | ISI26. Hugh, S, Siu, J, Hummel, T, et al. Olfactory testing in children using objective tools: comparison of Sniffin Sticks and University of Penn J Otolaryngol Head Neck Surg sylvania smell identification test (UPSIT). J. Otolaryngo.l Head Neck Surg. 2015;44(1):10.
Google Scholar | Crossref27. Doty, RL, Shaman, P, Dann, M. Development of the university of Pennsylvania smell identification test: a standardized microencapsulated test of olfactory function. Physiol. Behav. 1984;32(3):489-502.
Google Scholar | Crossref | Medline | ISI28. Doty, RL, Shaman, P, Kimmelman, C, Dann, M. University of Pennsylvania smell identification test: a rapid quantitative olfactory function test for the clinic. The Laryngoscope. 1984;94(2 Pt 1):176-178.
Google Scholar | Crossref | Medline29. Doty, RL, Newhouse, M, Azzalina, J. Internal consistency and short-term test-retest reliability of the University of Pennsylvania smell identification test. Chem. Senses. 1985;10(3):297-300.
Google Scholar | Crossref30. Smith, SM, Jenkinson, M, Woolrich, MW, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23(S1):208-219. https://doi.org/10.1016/j.neuroimage.2004.07.051
Google Scholar | Crossref | ISI31. Aarsland, D, Creese, B, Politis, M, et al. Cognitive decline in Parkinson disease. Nat. Rev. Neurol. 2017;13(4):217-231.
Google Scholar | Crossref | Medline32. Berendse, HW, Roos, DS, Raijmakers, P, Doty, RL. Motor and non - motor correlates of olfactory dysfunction in Parkinson's disease. J. Neurol. Sci. 2011;310(1-2):21-24.
Google Scholar | Crossref | Medline33. Alexander, AL, Hurley, SA, Samsonov, AA, et al. Characterization of cerebral white matter properties using quantitative magnetic resonance imaging stains. Brain Connectivity. 2011;1(6):423-446.
Google Scholar | Crossref | Medline34. Alexander, AL, Lee, JE, Lazar, M, Field, AS. Diffusion tensor imaging of the brain. Neurotherapeutics. 2007;4(3):316-329.
Google Scholar | Crossref | Medline | ISI35. Melzer, TR, Watts, R, MacAskill, MR, et al. White matter microstructure deteriorates across cognitive stages in Parkinson disease. Neurol. 2013;80(20):1841-1849.
Google Scholar | Crossref | Medline36. Agosta, F, Canu, E, Stefanova, E, et al. Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage. Hum. Brain Mapp. 2014;35(5):1921-1929.
Google Scholar | Crossref | Medline37. Kamagata, K, Motoi, Y, Tomiyama, H, et al. Relationship between cognitive impairment and white-matter alteration in Parkinson's disease with dementia: tract-based spatial statistics and tract-specific analysis. Eur. Radiol. 2013;23(7):1946-1955.
Google Scholar | Crossref | Medline38. Weintraub, D, Doshi, J, Koka, D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Arch. Neurol. 2011;68(12):1562-1568.
Google Scholar | Crossref | Medline39. Jia, X, Wang, Z, Yang, T, et al. Entorhinal Cortex atrophy in early, drug-naive Parkinson's disease with mild cognitive impairment. Aging. Dis. 2019;10(6):1221-1232. https://doi.org/10.14336/AD.2018.1116
Google Scholar | Crossref | Medline40. Hattori, T, Orimo, S, Aoki, S, et al. Cognitive status correlates with white matter alteration in Parkinson's disease. Hum. Brain. Mapp. 2012;33(3):727-739.
Google Scholar | Crossref | Medline | ISI41. Ogihara, H, Kobayashi, M, Nishida, K, Kitano, M, Takeuchi, K. Applicability of the cross-culturally modified University of Pennsylvania smell identification test in a Japanese population. Am. J. Rhinol. Allergy. 2011;25(6):404-410.
Google Scholar | SAGE Journals42. Muirhead, N, Benjamin, E, Saleh, H. Is the University of Pennsylvania smell identification test (UPSIT) valid for the UK population? Otorhinolaryngologist. 2013;6:99-103.
Google Scholar43. Evans, WJ, Cui, L, Starr, A. Olfactory event-related potentials in normal human subjects: effects of age and gender. Electroencephalogr Clin Neurophysiol. 1995;95(4):293-301. doi: 10.1016/0013-4694(95)00055-4. PMID: 8529560.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif